Close

Catyalyst Pharma (CPRX) Posts Q3 Loss of 5c/Share

November 9, 2015 4:28 PM EST

Catyalyst Pharma (NASDAQ: CPRX) reported Q3 EPS of ($0.05), which may not compare with the analyst estimate of ($0.07).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings